GlassScriptPhysician profile
William J Witcik
NPI 1619956547
$1,273.34
in general payments reported to CMS, 2019-2025
13 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $190 · 2021: $172 · 2022: $259 · 2023: $103 · 2024: $157 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $534.77 | 2019-2025 | Assurity, Jot Dx, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $184.48 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $118.23 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $69.38 | 2024 | |
| Inari Medical, INC. | $67.26 | 2020 | |
| Teleflex LLC | $59.35 | 2022-2023 | Turnpike |
| Cardiovascular Systems INC. | $58.39 | 2020-2022 | |
| Livanova USA, INC. | $56.09 | 2019 | |
| Biosense Webster, INC. | $44.08 | 2019-2021 | |
| Abiomed | $28.99 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $26.07 | 2019-2022 | |
| Terumo Medical Corporation | $13.91 | 2019 | |
| Philips North America LLC | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Witcik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.